|
|
|
Insider
Information: |
Wong Roderick |
Relationship: |
10% Owner |
City: |
Patterson |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
57,532,221 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$1,241,375,912 |
|
|
Total
Shares |
57,532,221 |
|
|
Total
Value |
$1,241,375,912 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
0
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
3
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
13.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Penwest Pharmaceuticals Co |
PPCO |
Director |
2010-09-20 |
0 |
2010-06-30 |
0 |
Premium* |
|
Milestone Pharmaceuticals Inc. |
MIST |
10% Owner |
2019-05-09 |
0 |
2023-03-22 |
3,256,102 |
Premium* |
|
Stoke Therapeutics, Inc. |
STOK |
10% Owner |
2019-06-19 |
0 |
2019-11-08 |
3,544,248 |
Premium* |
|
Dermtech Ord Shs |
DMTK |
10% Owner |
|
0 |
2022-11-04 |
3,018,666 |
Premium* |
|
Immunovant Inc |
IMVT |
Chief Executive Office... |
2019-11-07 |
0 |
2019-12-11 |
902,498 |
Premium* |
|
Tela Bio, Inc. |
TELA |
10% Owner |
2019-12-13 |
0 |
2019-12-17 |
1,139,358 |
Premium* |
|
Avidity Biosciences, Inc. |
RNA |
MP and CIO |
2020-06-16 |
0 |
2021-08-04 |
4,795,000 |
Premium* |
|
Athira Pharma, Inc. |
ATHA |
10% Owner |
|
0 |
2020-09-18 |
2,668,913 |
Premium* |
|
Tarsus Pharmaceuticals, Inc. |
TARS |
10% Owner |
|
0 |
2021-05-07 |
2,013,601 |
Premium* |
|
Landos Biopharma, Inc. |
LABP |
10% Owner |
2021-02-04 |
0 |
2022-09-23 |
3,975,722 |
Premium* |
|
Prometheus Biosciences, Inc. |
RXDX |
10% Owner |
2021-03-16 |
0 |
2021-03-16 |
3,264,031 |
Premium* |
|
Renovacor Ord Shs |
RCOR |
10% Owner |
2021-09-02 |
0 |
2022-12-01 |
0 |
Premium* |
|
Orchestra BioMed Holdings Inc. |
OBIO |
10% Owner |
2022-07-22 |
0 |
2023-04-13 |
5,620,645 |
Premium* |
|
Rocket Pharmaceuticals |
RCKT |
Director, 10% Owner |
2022-10-06 |
0 |
2023-08-28 |
18,157,605 |
Premium* |
|
Cargo Therapeutics, Inc. |
CRGX |
10% Owner |
|
0 |
2024-01-12 |
5,175,832 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ATHA |
Athira Pharma, Inc. |
10% Owner |
|
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
383,782 |
|
- |
|
ATHA |
Athira Pharma, Inc. |
10% Owner |
|
2020-09-18 |
4 |
B |
$17.00 |
$12,750,000 |
I/I |
750,000 |
2,668,913 |
1.5 |
- |
|
ATHA |
Athira Pharma, Inc. |
10% Owner |
|
2020-09-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,535,131 |
1,918,913 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2020-06-16 |
4 |
B |
$18.00 |
$17,100,000 |
I/I |
950,000 |
3,995,000 |
2.25 |
% |
|
RNA |
Avidity Biosciences, Inc. |
Director |
|
2020-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
3,045,000 |
3,045,000 |
0 |
- |
|
RNA |
Avidity Biosciences, Inc. |
MP and CIO |
|
2021-08-04 |
4 |
B |
$18.00 |
$14,400,000 |
I/I |
800,000 |
4,795,000 |
1.99 |
% |
|
CRGX |
Cargo Therapeutics, Inc. |
10% Owner |
|
2023-11-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,175,832 |
|
- |
|
CRGX |
Cargo Therapeutics, Inc. |
10% Owner |
|
2024-01-12 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,842,499) |
5,175,832 |
0 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2019-08-29 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,386,871 |
|
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-02-28 |
4 |
B |
$10.50 |
$1,600,788 |
I/I |
152,456 |
2,539,327 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-03-02 |
4 |
B |
$12.83 |
$192,428 |
I/I |
15,000 |
2,554,327 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-03-03 |
4 |
B |
$14.52 |
$188,713 |
I/I |
13,000 |
2,567,327 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-03-04 |
4 |
B |
$14.75 |
$65,593 |
I/I |
4,447 |
2,571,774 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-03-05 |
4 |
B |
$14.61 |
$350,088 |
I/I |
23,955 |
2,595,729 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-03-31 |
4 |
B |
$11.26 |
$56,321 |
I/I |
5,000 |
2,600,729 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-04-01 |
4 |
B |
$10.41 |
$276,316 |
I/I |
26,539 |
2,627,268 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-05-27 |
4 |
A |
$0.00 |
$0 |
I/I |
228,498 |
2,855,766 |
0 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2020-08-17 |
4 |
OE |
$9.54 |
$300,033 |
I/I |
31,450 |
2,887,216 |
0 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2021-01-07 |
4 |
B |
$29.50 |
$5,900,000 |
I/I |
200,000 |
3,087,216 |
1.5 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2021-01-26 |
4 |
OE |
$9.54 |
$300,033 |
I/I |
31,450 |
3,118,666 |
0 |
- |
|
DMTK |
Dermtech Ord Shs |
10% Owner |
|
2022-11-04 |
4 |
S |
$1.77 |
$176,660 |
I/I |
(100,000) |
3,018,666 |
0 |
- |
|
IMVT |
Immunovant Inc |
Chief Executive Officer |
|
2019-11-07 |
4 |
B |
$10.18 |
$178,150 |
I/I |
17,500 |
17,500 |
2.66 |
- |
|
IMVT |
Immunovant Inc |
Chief Executive Officer |
|
2019-11-11 |
4 |
B |
$10.18 |
$132,340 |
I/I |
13,000 |
30,500 |
2.66 |
- |
|
IMVT |
Immunovant Inc |
Chief Executive Officer |
|
2019-11-12 |
4 |
B |
$10.17 |
$1,017,000 |
I/I |
100,000 |
130,500 |
2.66 |
- |
|
IMVT |
Immunovant Inc |
Chief Executive Officer |
|
2019-11-13 |
4 |
B |
$10.17 |
$132,210 |
I/I |
13,000 |
143,500 |
2.66 |
- |
|
93 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|